vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and Udemy, Inc. (UDMY). Click either name above to swap in a different company.

Udemy, Inc. is the larger business by last-quarter revenue ($194.0M vs $142.0M, roughly 1.4× Oncology Institute, Inc.). Udemy, Inc. runs the higher net margin — -1.2% vs -5.3%, a 4.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -3.0%). Udemy, Inc. produced more free cash flow last quarter ($15.0M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -0.7%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

Udemy is a US-based education technology company. Founded as a massive open online course (MOOC) provider in 2010 by Eren Bali, Gagan Biyani, and Oktay Caglar; the company is based in San Francisco, California, with offices in the United States, Australia, India, Ireland, Mexico and Turkey. Its education platform allows both the creation and sharing of online courses. By early 2025, Udemy claimed to have millions of individual users. Courses are typically video-based and on-demand.

TOI vs UDMY — Head-to-Head

Bigger by revenue
UDMY
UDMY
1.4× larger
UDMY
$194.0M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+44.6% gap
TOI
41.6%
-3.0%
UDMY
Higher net margin
UDMY
UDMY
4.1% more per $
UDMY
-1.2%
-5.3%
TOI
More free cash flow
UDMY
UDMY
$12.8M more FCF
UDMY
$15.0M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-0.7%
UDMY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TOI
TOI
UDMY
UDMY
Revenue
$142.0M
$194.0M
Net Profit
$-7.5M
$-2.3M
Gross Margin
66.0%
Operating Margin
-4.9%
-1.8%
Net Margin
-5.3%
-1.2%
Revenue YoY
41.6%
-3.0%
Net Profit YoY
43.0%
76.4%
EPS (diluted)
$-0.04
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
UDMY
UDMY
Q4 25
$142.0M
$194.0M
Q3 25
$136.6M
$195.7M
Q2 25
$119.8M
$199.9M
Q1 25
$104.4M
$200.3M
Q4 24
$100.3M
$199.9M
Q3 24
$99.9M
$195.4M
Q2 24
$98.6M
$194.4M
Q1 24
$94.7M
$196.8M
Net Profit
TOI
TOI
UDMY
UDMY
Q4 25
$-7.5M
$-2.3M
Q3 25
$-16.5M
$1.6M
Q2 25
$-17.0M
$6.3M
Q1 25
$-19.6M
$-1.8M
Q4 24
$-13.2M
$-9.9M
Q3 24
$-16.1M
$-25.3M
Q2 24
$-15.5M
$-31.8M
Q1 24
$-19.9M
$-18.3M
Gross Margin
TOI
TOI
UDMY
UDMY
Q4 25
66.0%
Q3 25
65.9%
Q2 25
66.1%
Q1 25
64.6%
Q4 24
63.6%
Q3 24
63.0%
Q2 24
62.3%
Q1 24
61.2%
Operating Margin
TOI
TOI
UDMY
UDMY
Q4 25
-4.9%
-1.8%
Q3 25
-5.9%
-0.1%
Q2 25
-9.4%
2.0%
Q1 25
-9.5%
-2.2%
Q4 24
-11.9%
-5.8%
Q3 24
-13.9%
-15.1%
Q2 24
-16.6%
-13.1%
Q1 24
-19.0%
-11.5%
Net Margin
TOI
TOI
UDMY
UDMY
Q4 25
-5.3%
-1.2%
Q3 25
-12.1%
0.8%
Q2 25
-14.2%
3.1%
Q1 25
-18.8%
-0.9%
Q4 24
-13.1%
-4.9%
Q3 24
-16.1%
-12.9%
Q2 24
-15.7%
-16.4%
Q1 24
-21.0%
-9.3%
EPS (diluted)
TOI
TOI
UDMY
UDMY
Q4 25
$-0.04
$-0.01
Q3 25
$-0.14
$0.01
Q2 25
$-0.15
$0.04
Q1 25
$-0.21
$-0.01
Q4 24
$-0.14
$-0.06
Q3 24
$-0.18
$-0.17
Q2 24
$-0.17
$-0.21
Q1 24
$-0.22
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
UDMY
UDMY
Cash + ST InvestmentsLiquidity on hand
$358.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$210.5M
Total Assets
$164.7M
$617.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
UDMY
UDMY
Q4 25
$358.7M
Q3 25
$371.2M
Q2 25
$392.0M
Q1 25
$357.0M
Q4 24
$354.4M
Q3 24
$357.1M
Q2 24
$9.9M
$420.9M
Q1 24
$29.8M
$430.7M
Stockholders' Equity
TOI
TOI
UDMY
UDMY
Q4 25
$-15.7M
$210.5M
Q3 25
$-12.3M
$221.8M
Q2 25
$-9.0M
$233.4M
Q1 25
$5.1M
$209.4M
Q4 24
$3.6M
$197.4M
Q3 24
$15.5M
$196.3M
Q2 24
$29.2M
$252.3M
Q1 24
$41.3M
$296.5M
Total Assets
TOI
TOI
UDMY
UDMY
Q4 25
$164.7M
$617.7M
Q3 25
$163.6M
$618.9M
Q2 25
$159.8M
$644.0M
Q1 25
$164.0M
$639.0M
Q4 24
$172.7M
$605.6M
Q3 24
$179.2M
$608.9M
Q2 24
$179.6M
$671.9M
Q1 24
$204.5M
$708.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
UDMY
UDMY
Operating Cash FlowLast quarter
$3.2M
$15.5M
Free Cash FlowOCF − Capex
$2.2M
$15.0M
FCF MarginFCF / Revenue
1.5%
7.7%
Capex IntensityCapex / Revenue
0.7%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$81.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
UDMY
UDMY
Q4 25
$3.2M
$15.5M
Q3 25
$-12.6M
$15.7M
Q2 25
$-10.2M
$44.2M
Q1 25
$-5.0M
$12.2M
Q4 24
$4.2M
$9.6M
Q3 24
$819.0K
$-6.1M
Q2 24
$-15.7M
$28.6M
Q1 24
$-15.9M
$21.0M
Free Cash Flow
TOI
TOI
UDMY
UDMY
Q4 25
$2.2M
$15.0M
Q3 25
$-13.2M
$15.1M
Q2 25
$-11.4M
$41.9M
Q1 25
$-5.3M
$9.8M
Q4 24
$2.4M
$8.4M
Q3 24
$417.0K
$-6.7M
Q2 24
$-17.5M
$28.2M
Q1 24
$-16.5M
$20.8M
FCF Margin
TOI
TOI
UDMY
UDMY
Q4 25
1.5%
7.7%
Q3 25
-9.7%
7.7%
Q2 25
-9.5%
21.0%
Q1 25
-5.1%
4.9%
Q4 24
2.4%
4.2%
Q3 24
0.4%
-3.4%
Q2 24
-17.7%
14.5%
Q1 24
-17.4%
10.6%
Capex Intensity
TOI
TOI
UDMY
UDMY
Q4 25
0.7%
0.3%
Q3 25
0.4%
0.3%
Q2 25
1.0%
1.1%
Q1 25
0.3%
1.2%
Q4 24
1.8%
0.6%
Q3 24
0.4%
0.3%
Q2 24
1.9%
0.2%
Q1 24
0.6%
0.1%
Cash Conversion
TOI
TOI
UDMY
UDMY
Q4 25
Q3 25
9.58×
Q2 25
7.06×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

UDMY
UDMY

Segment breakdown not available.

Related Comparisons